Vienna to use public defibrillators to fight heart attacks

September 27, 2012

Vienna will introduce 60 public defibrillators around the city over the coming months, in a bid to save lives by promoting quicker first aid in the event of a heart attack, authorities said Thursday.

Over 10,000 people die every year in Austria following .

"There's only one mistake you can make, that's to do nothing," Harry Kopietz, head of the regional parliament and president of the association Puls, which is backing the project, told journalists.

The , which help restore the heart's normal rhythm via an , will be installed in stand-alone LED advertising boards, such as on and .

To help users who may otherwise feel intimidated, anyone who uses the device will be automatically connected to emergency services who can assist with reviving the patient.

An ambulance will be dispatched at the same time, thanks to a built-in global-positioning system (GPS), and the device itself will also explain what needs to be done.

Limited oxygen can provoke irreversible brain damage within three minutes of a , which is why quick action is vital, without waiting for rescue services arrive, Puls manager Mario Krammel said.

The rate of survival for victims of cardiac arrest was up to 50 percent higher if they were treated promptly, added Klaus Marstaller of the Medical University of Vienna.

A link on the Puls website and a smartphone app will indicate where defibrillators are located.

The project's estimated initial cost of one million euros ($1.3 million) will be entirely covered by the Gewista agency, which handles all public advertising in Vienna.

It calculated it would earn the money back through advertising, as the defibrillator pillars will still act as advertising signs on one side.

Further defibrillators were to be introduced regularly in the future.

Similar projects have already been tested in Britain, France, Canada and Italy.

Explore further: Wearable defibrillator can prevent death in people with arrhythmias

Related Stories

Wearable defibrillator can prevent death in people with arrhythmias

November 13, 2011
A wearable defibrillator can prevent sudden death in people with dangerous heart arrhythmias, according to research presented at the American Heart Association's Scientific Sessions 2011.

Sharp decrease in deaths from sudden cardiac arrest

November 23, 2011
Only a few decades ago, sudden cardiac arrest was a death sentence. Today, a victim of sudden cardiac arrest is saved roughly once every six hours in Sweden, reveals a thesis from the Sahlgrenska Academy at the University ...

Commonly used defibrillators raise risk of problems

August 31, 2011
When it comes to defibrillators, simpler may be safer, even though more complex machines are used on a majority of patients.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.